CN103384516B - 含聚乙二醇的制剂 - Google Patents

含聚乙二醇的制剂 Download PDF

Info

Publication number
CN103384516B
CN103384516B CN201180063942.9A CN201180063942A CN103384516B CN 103384516 B CN103384516 B CN 103384516B CN 201180063942 A CN201180063942 A CN 201180063942A CN 103384516 B CN103384516 B CN 103384516B
Authority
CN
China
Prior art keywords
solid preparation
peg
solid
mannitol
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201180063942.9A
Other languages
English (en)
Chinese (zh)
Other versions
CN103384516A (zh
Inventor
P·斯坦因
I·考克斯
S·史密斯
L·琼斯
J·普莱斯尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Norgine BV
Original Assignee
Norgine BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1018647.6A external-priority patent/GB201018647D0/en
Priority claimed from GBGB1104049.0A external-priority patent/GB201104049D0/en
Priority claimed from GBGB1107626.2A external-priority patent/GB201107626D0/en
Application filed by Norgine BV filed Critical Norgine BV
Publication of CN103384516A publication Critical patent/CN103384516A/zh
Application granted granted Critical
Publication of CN103384516B publication Critical patent/CN103384516B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/77—Polymers containing oxygen of oxiranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/08—Ethers or acetals acyclic, e.g. paraformaldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CN201180063942.9A 2010-11-04 2011-11-04 含聚乙二醇的制剂 Expired - Fee Related CN103384516B (zh)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
GB1018647.6 2010-11-04
GBGB1018647.6A GB201018647D0 (en) 2010-11-04 2010-11-04 Formulations
US41210910P 2010-11-10 2010-11-10
US61/412,109 2010-11-10
GBGB1104049.0A GB201104049D0 (en) 2011-03-09 2011-03-09 Formulations
GB1104049.0 2011-03-09
GBGB1107626.2A GB201107626D0 (en) 2011-05-06 2011-05-06 Formulations
GB1107626.2 2011-05-06
PCT/GB2011/001560 WO2012059724A1 (en) 2010-11-04 2011-11-04 Formulations comprising polyethylene glycol

Publications (2)

Publication Number Publication Date
CN103384516A CN103384516A (zh) 2013-11-06
CN103384516B true CN103384516B (zh) 2017-02-15

Family

ID=44999794

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201180063942.9A Expired - Fee Related CN103384516B (zh) 2010-11-04 2011-11-04 含聚乙二醇的制剂

Country Status (20)

Country Link
US (3) US20130225692A1 (enExample)
EP (1) EP2635264B8 (enExample)
JP (1) JP5872573B2 (enExample)
KR (1) KR20130101102A (enExample)
CN (1) CN103384516B (enExample)
AR (1) AR083769A1 (enExample)
AU (1) AU2011324995B2 (enExample)
BE (1) BE1019493A3 (enExample)
BR (1) BR112013010884A2 (enExample)
CA (1) CA2816835A1 (enExample)
EA (1) EA024566B1 (enExample)
ES (1) ES2405531B1 (enExample)
IL (1) IL225892A0 (enExample)
MX (1) MX342181B (enExample)
MY (1) MY164204A (enExample)
NL (1) NL2007716C2 (enExample)
NZ (1) NZ611148A (enExample)
SG (1) SG190018A1 (enExample)
TW (1) TWI520730B (enExample)
WO (1) WO2012059724A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI535461B (zh) 2011-03-11 2016-06-01 諾金私人有限公司 結腸清潔溶液、用於製備該溶液之組成物、包含該組成物或溶液之套組、與製備該溶液之方法
US20130209522A1 (en) * 2012-02-06 2013-08-15 University Of Utah Research Foundation Drug Release from a Polymer-Controlled Local Antibiotic Delivery System Using a Degradable Bone Graft
SG10201702005VA (en) 2012-09-11 2017-04-27 Norgine Bv Compositions comprising peg and ascorbate
US9889235B2 (en) 2013-02-05 2018-02-13 University Of Utah Research Foundation Implantable devices for bone or joint defects
SI2968174T1 (sl) 2013-03-15 2020-02-28 Braintree Laboratories, Inc. Dvojna uporaba tablet oralnega farmacevtskega sestavka sulfatnih soli in metode njihove uporabe
MX2016014230A (es) * 2014-04-29 2017-05-03 Colonaryconcepts Llc Alimentos, sistemas, metodos y kits para proporcionar reemplazo de electrolitos.
JP2018532702A (ja) * 2015-09-01 2018-11-08 コロナリーコンセプツ エルエルシー 下剤製剤及び製造
CN109328035B (zh) 2016-06-15 2022-05-10 株式会社岛津制作所 放射线摄影装置
FR3056109B1 (fr) 2016-09-21 2019-10-11 Pierre Fabre Medicament Utilisation de formulations solides de polyethylene glycol dans le traitement de la constipation
CN112386577B (zh) * 2019-08-16 2024-01-23 北京天衡药物研究院有限公司 一种治疗便秘的组合物

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1950097A (zh) * 2004-04-23 2007-04-18 诺金欧洲公司 含有聚乙二醇和电解质的压制药物组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5710183A (en) * 1995-07-14 1998-01-20 Halow; George M. Laxative/antidiarrheal composition comprising polyethylene glycol and fiber bulking agent
CA2516291C (en) * 2003-02-28 2012-02-14 Alk-Abello A/S Dosage form having a saccharide matrix
WO2006122104A1 (en) * 2005-05-06 2006-11-16 Salix Pharmaceuticals, Inc. Polyethylene glycol colonic purgative composition
CO5790164A1 (es) * 2006-08-10 2007-08-31 Procaps S A Composicion farmaceutica solida que incluye en combinacion un agente regulador de la motilidad intestinal y un agente antiflatulento

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1950097A (zh) * 2004-04-23 2007-04-18 诺金欧洲公司 含有聚乙二醇和电解质的压制药物组合物

Also Published As

Publication number Publication date
MY164204A (en) 2017-11-30
BE1019493A3 (fr) 2012-07-03
AU2011324995A1 (en) 2013-05-02
TW201223522A (en) 2012-06-16
MX342181B (es) 2016-09-20
CA2816835A1 (en) 2012-05-10
WO2012059724A8 (en) 2013-06-06
EP2635264B8 (en) 2018-07-18
ES2405531A2 (es) 2013-05-31
IL225892A0 (en) 2013-06-27
AR083769A1 (es) 2013-03-20
BR112013010884A2 (pt) 2016-08-02
AU2011324995B2 (en) 2015-12-24
MX2013004972A (es) 2013-08-27
ES2405531R1 (es) 2013-06-07
KR20130101102A (ko) 2013-09-12
WO2012059724A1 (en) 2012-05-10
EA024566B1 (ru) 2016-09-30
US20160193245A1 (en) 2016-07-07
EP2635264B1 (en) 2018-05-30
EA201300539A1 (ru) 2013-09-30
TWI520730B (zh) 2016-02-11
US20130225692A1 (en) 2013-08-29
SG190018A1 (en) 2013-06-28
CN103384516A (zh) 2013-11-06
NL2007716A (en) 2012-05-07
ES2405531B1 (es) 2014-06-11
NL2007716C2 (en) 2012-11-13
EP2635264A1 (en) 2013-09-11
JP2014500246A (ja) 2014-01-09
US20170296575A1 (en) 2017-10-19
NZ611148A (en) 2015-09-25
JP5872573B2 (ja) 2016-03-01

Similar Documents

Publication Publication Date Title
CN103384516B (zh) 含聚乙二醇的制剂
US6406717B2 (en) Rapid-melt semi-solid compositions, methods of making same and methods of using same
US20080020065A1 (en) Rapid-melt compositions, methods of making same and method of using same
US20110300216A1 (en) Chewable, swallowable and effervescent solid dosage form for oral delivery of pharmaceutical actives
US20160228467A1 (en) Peg or peg block copolymer for treating colorectal cancer
US20100278913A1 (en) Chewable tablet
JP2013540726A (ja) 便秘薬
US11864570B2 (en) Therapeutic composition including carbonated solution
JPH10287555A (ja) チュアブル錠
US20220110900A1 (en) Solid nutrient compositions and associated methods
FR2967069A3 (fr) Formulations
UA108135C2 (uk) Тверда композиція для прийому всередину (варіанти), спосіб профілактики шлунково-кишкових розладів або підтримання здорового стану шлунково-кишкового тракту за її допомогою (варіанти) та упаковка, що її містить
IE20110480U1 (en) A solid formulation for oral administration comprising polyethylene glycol and mannitol
IES86031Y1 (en) A solid formulation for oral administration comprising polyethylene glycol and mannitol

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20170215

Termination date: 20181104

CF01 Termination of patent right due to non-payment of annual fee